Aftercare without CC/MCC DRG Reimbursement & Medicare

DRG 950 covers inpatient admissions for routine aftercare related to prior procedures without Complication or Comorbidity or Major Complication or Comorbidity, focusing on low-acuity, post-procedural management. This grouping matters for inpatient reimbursement because it assigns lower payment relative to more complex Diagnostic-Related Groups and influences hospital case mix and resource allocation under Medicare rules.

DRG 950 Overview

DRG 950, Aftercare without Complication or Comorbidity, captures hospital inpatient stays for routine aftercare services related to prior therapeutic or diagnostic procedures where no Complication or Comorbidity or Major Complication or Comorbidity is present. Typical cases include uncomplicated follow-up care, dressing changes, suture removal, and routine monitoring after previous treatment. This Diagnosis-Related Group matters for Medicare payment because it groups low-acuity aftercare admissions into a lower-paying category that affects hospital case mix index and reimbursement planning.

Studies assessing effectiveness of structured post-acute rehabilitation and care coordination programs: randomized or pragmatic comparative studies enroll patients discharged to skilled nursing, inpatient rehabilitation, or home with home health services after a hospitalization that requires ongoing skilled care but without major complications (for example postoperative wound care, prolonged physical therapy needs, or chronic disease management escalation). These trials examine functional recovery, readmission rates, and resource use when structured multidisciplinary pathways (standardized therapy intensity, dedicated case management, or tele-rehab follow-up) are applied versus usual post-discharge care. Results are directly relevant to hospitals and payers because they inform which post-acute strategies reduce readmissions, shorten length of stay in post-acute settings, and optimize reimbursement under bundled or capitated payment models for aftercare patients.
Comparative effectiveness studies of care setting and intensity for medically stable patients needing continued skilled services: observational cohort or pragmatic trials compare outcomes for patients receiving similar aftercare needs in different settings (home health vs skilled nursing facility vs inpatient rehab) and at different intensity levels of therapy or nursing. The population includes clinically stable patients without major complications (no CC/MCC) who nonetheless require ongoing monitoring, wound care, intravenous antibiotics, or physical/occupational therapy continuity; studies measure functional outcomes, complications, patient satisfaction, and total cost of care. These findings help clinicians and payers determine which care settings and service intensities deliver the best value and align incentives with DRG 950 reimbursement patterns.
Post-discharge outcomes and predictive-modeling research to reduce preventable utilization: prospective cohort studies and development/validation of prediction tools focus on identifying patients categorized under aftercare without CC/MCC who are at elevated risk for early readmission, adverse events, or deterioration after transfer to lower-acuity settings. Researchers evaluate biomarkers, functional scores, social determinants, and care-process variables to create risk-stratification algorithms and targeted monitoring interventions. This research supports providers and payers by enabling targeted resource allocation (e.g., intensified follow-up for high-risk patients) to prevent costly returns to acute care and to improve the efficiency of aftercare covered under DRG 950.

Studies assessing effectiveness of structured post-acute rehabilitation and care coordination programs: randomized or pragmatic comparative studies enroll patients discharged to skilled nursing, inpatient rehabilitation, or home with home health services after a hospitalization that requires ongoing skilled care but without major complications (for example postoperative wound care, prolonged physical therapy needs, or chronic disease management escalation). These trials examine functional recovery, readmission rates, and resource use when structured multidisciplinary pathways (standardized therapy intensity, dedicated case management, or tele-rehab follow-up) are applied versus usual post-discharge care. Results are directly relevant to hospitals and payers because they inform which post-acute strategies reduce readmissions, shorten length of stay in post-acute settings, and optimize reimbursement under bundled or capitated payment models for aftercare patients.
Comparative effectiveness studies of care setting and intensity for medically stable patients needing continued skilled services: observational cohort or pragmatic trials compare outcomes for patients receiving similar aftercare needs in different settings (home health vs skilled nursing facility vs inpatient rehab) and at different intensity levels of therapy or nursing. The population includes clinically stable patients without major complications (no CC/MCC) who nonetheless require ongoing monitoring, wound care, intravenous antibiotics, or physical/occupational therapy continuity; studies measure functional outcomes, complications, patient satisfaction, and total cost of care. These findings help clinicians and payers determine which care settings and service intensities deliver the best value and align incentives with DRG 950 reimbursement patterns.
Post-discharge outcomes and predictive-modeling research to reduce preventable utilization: prospective cohort studies and development/validation of prediction tools focus on identifying patients categorized under aftercare without CC/MCC who are at elevated risk for early readmission, adverse events, or deterioration after transfer to lower-acuity settings. Researchers evaluate biomarkers, functional scores, social determinants, and care-process variables to create risk-stratification algorithms and targeted monitoring interventions. This research supports providers and payers by enabling targeted resource allocation (e.g., intensified follow-up for high-risk patients) to prevent costly returns to acute care and to improve the efficiency of aftercare covered under DRG 950.

OpenPayer

Summary & Overview

Aftercare without CC/MCC: Inpatient Reimbursement Overview

DRG 950 Overview

Clinical Trials

Related Codes

Clinical Trials

Related Codes